Skip to main content

MoneyWorks4Me

Granules India informs about press release

18 Apr 2019 Evaluate

Granules India has informed about submission of a copy of Press Release issued by the Company for receiving the approval from US FDA for the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..